did-you-know? rent-now

Rent More, Save More! Use code: ECRENTAL

did-you-know? rent-now

Rent More, Save More! Use code: ECRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

9784431402800

Therapy for Viral Hepatitis and Prevention of Hepatocelluar Carcinoma

by ;
  • ISBN13:

    9784431402800

  • ISBN10:

    4431402802

  • Format: Hardcover
  • Copyright: 2004-01-01
  • Publisher: Springer Verlag
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $159.00 Save up to $125.59
  • Digital
    $72.39
    Add to Cart

    DURATION
    PRICE

Summary

The first single-topic annual conference on hepatology in Japan was held in November 2002 to discuss therapies for viral hepatitis and the prevention of hepatocellular carcinoma (HCC). Bringing together researchers and clinicians from North America, Europe, Japan, and other parts of Asia, the conference included symposia on the hepatitis C replicon system, new antivirals that lower or prevent the incidence of HCC, and transplantation in cases of hepatitis B and C, as well as new treatment modalities for viral hepatitis and preventative measures for HCC. With the rising number of HCC cases worldwide, this collection of papers presented at the conference provides a valuable, up-to-date resource and reference for all professionals involved in the treatment and prevention of viral hepatitis and hepatocellular carcinoma.

Table of Contents

Inaugurating the Single-Topic Conference v
Preface vii
Organization of the Symposium xi
1 Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma
1.1 Opening Lecture: What is Accomplished and What is Needed
M. OMATA
3(22)
2 Lamivudine Therapy for Hepatitis B
2.1 New Anti-Virals Against Wild-Type and Lamivudine-Resistant Hepatitis B Virus
N. KATO, S.K. ONO-NITA, and M. OMATA
25(7)
2.2 Lamivudine Therapy of Hepatitis B in Japan
M. SATA
32(6)
2.3 Early Detection of Lamivudine Resistant Mutant in Chronic Hepatitis B Patients Using a Novel Sensitive Method
T. OKANOUE, K. MORI, T. KIRISHIMA, and M. MINAMI
38(9)
3 New Anti-Virals: HBV
3.1 New Antiviral Treatment for Chronic Hepatitis B
M.-F. YUEN and C.-L. LAI
47(10)
3.2 New Antiviral Therapy: Adefovir Dipivoxil for HBV
M. PETERS
57(6)
3.3 Development of Entecavir: Superior Therapy for the Management of Chronic Hepatitis B Viral Infection
D. DEHERTOGH, R. COLONNO, W. FISKE, and A. CROSS
63(14)
4 Therapy for Hepatitis B and Prevention of HCC
4.1 Therapy of Hepatitis B and Prevention of Hepatocellular Carcinoma
N. LEUNG
77(7)
4.2 Differences of Clinical Characteristics Among Japanese Patients with Hepatitis B Virus Genotypes B and C
M. MIZOKAMI and E. ORITO
84(13)
5 HCV Replicon System
5.1 Establishment of a New Hepatitis C Virus-lb Replicon
N. ENOMOTO, N. SAKAMOTO, M. KUROSAKI, S. MAEKAWA, Y. TANABE, T. YAMASHIRO, C.-H. CHEN, M. NAKAGAWA, N. KANAZAWA, H. WATANABE, C. SATO, and M. WATANABE
97(11)
5.2 Hepatitis C Virus Replication in Cell Culture
M. FRESE, V. LOHMANN, T. PIETSCHMANN, A. KAUL, N. KRIEGER, J. BUKH, and R. BARTENSCHLAGER
108(15)
5.3 Characterization of the Interferon Alpha Response Against HCV in Hepatoma Cells
C. SEEGER, Q. ZHU, and J.-T. Guo
123(10)
6 New Anti-Virals: HCV
6.1 Hepatitis C: Development of a Ribavirin Liver-Targeting Prodrug
J.Y.N. LAU
133(7)
6.2 HCV Replicon Inhibitors: Mode of Action and Resistance Mapping
R.T. SARISKY
140(17)
7 Interferon Therapy for Hepatitis C
7.1 Interferon Treatment Not Only Reduces the Risk of Hepatocellular Carcinoma But Also Improves Mortality in Patients with Chronic Hepatitis C Showing Biochemical Response, Especially in Patients with Advanced Liver Fibrosis
A. KASAHARA and N. HAYASHI
157(10)
7.2 Favorable Outcome of Patients with C-Viral Liver Disease Treated with Interferon
O. YOKOSUKA, F. IMAZEKI, S. KAWAI, and K. FUKAI
167(9)
7.3 IFN Receptor and IFN Signals
H. YATSUHASHI
176(13)
8 Therapy for Hepatitis C and Prevention of HCC
8.1 Management and Treatment of Hepatitis C
L.B. SEEFF
189(10)
8.2 Hepatitis C Virus and Hepatocellular Carcinoma
M.J. TONG
199(10)
8.3 Randomized Trial of Post-Operative Interferon Therapy After Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma and Long-Term Outcome
S. NISHIGUCHI and S. KUBO
209(10)
8.4 Roles of Antiviral Therapy in Chronic Hepatitis C Patients Should be Different According to the Stages of Liver Disease Progression
Y. SHIRATORI
219(10)
8.5 Significance of Sustained Inflammation in the Development of HCC from HCV-Associated Cirrhotic Patients and the Prevention of HCC by Anti-Inflammatory Agents
K. TARAO
229(12)
9 Chemoprevention and Therapy for HCC
9.1 Chemoprevention of Hepatocellular Carcinoma with Retinoid
H. MORIWAKI
241(8)
9.2 Vitamin K2 Administration Improves the Prognoses of Patients with Hepatocellular Carcinoma Presenting High Levels of Serum Des-γ-Carboxy Prothrombin
Y. KOIKE, Y. SHIRATORI, H. YOSHIDA, and M. OMATA
249(2)
9.3 Combination Chemotherapy for Advanced Hepatocellular Carcinoma
S. KANEKO
251(7)
9.4 Combined Intra-Arterial 5-Fluorouracil and Subcutaneous Interferon-Alpha Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombi in the Major Portal Branches
M. MONDEN, M. SAKON, and H. NAGANO
258(15)
10 Transplantation for HBV and HCV
10.1 Liver Transplantation for Hepatitis B Virus-Related Liver Disease
S.B. PORTER and K.R. REDDY
273(10)
10.2 Living Donor Liver Transplantation for Hepatitis B and C Cirrhosis
Y. SUGAWARA and M. MAKUUCHI
283(10)
10.3 Living Donor Liver Transplantation for HBV-/HCV-Related Diseases
T. KIUCHI and K. TANAKA
293

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program